Overfatness, stunting and physical inactivity are determinants of plasminogen activator inhibitor-1activity, fibrinogen and thrombing-antithrombin complex in African adolescents

Blood Coagulation and Fibrinolysis

Volumn 19, Issue 5, 2008, Pages 361-368

  Nienaber, Cornelie ^a   Pieters, Marlien ^a   Kruger, Salome H ^a   Stonehouse, Welma ^b   Vorster, Hester H ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

^b MASSEY UNIVERSITY   (New Zealand)

Author keywords

Fibrinogen; Overfatness; Physical activity; Plasminogen activator inhibitor 1 activity; Stunting; Thrombinantithrombin complex

Indexed keywords

BLOOD CLOTTING FACTOR 8C; C REACTIVE PROTEIN; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN ANTITHROMBIN COMPLEX;

ADOLESCENT; AFRICA; AGE DISTRIBUTION; ARTICLE; BODY FAT; BODY HEIGHT; CARDIOVASCULAR DISEASE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME ACTIVITY; FEMALE; FITNESS; HEMOSTASIS; HIGH RISK POPULATION; HUMAN; IMMOBILIZATION; INFANT; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MATURITY; MUSCLE MASS; OBESITY; PHYSICAL ACTIVITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SEX RATIO; STUNTING SYNDROME;

ADOLESCENT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; ANTITHROMBINS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; FACTOR VIII; FEMALE; FIBRINOGEN; HEMOSTASIS; HUMANS; MALE; MOTOR ACTIVITY; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; SEX FACTORS; SOUTH AFRICA; THROMBIN;

EID: 67649528950     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328304b61a     Document Type: Article

References (61)

1. Ajjan R, Grant PJ. Coagulation and atherothrombotic disease. Atherosclerosis 2006; 186:240-259.
2. Kullo IJ, Gau GT, Tajik AJ. Novel risk factors for atherosclerosis. Mayo Clin Proc 2000; 75:369-380.
3. Sueishi K, Ichikawa K, Kato K, Nakagawa K, Chen YX. Atherosclerosis: coagulation and fibrinolysis. Semin Thromb Hemost 1998; 24:255-260.
4. Stamler J, Greenland P, Neaton JD. The established major risk factors underlying epidemic coronary and cardiovascular disease. CVD Prev 1998; 1:82-97.
5. Davia JE, Hallal FJ, Cheitlin MD, Gregoratos G, McCarty R, Foote W. Coronary artery disease in young patients: arteriographic and clinical review of 40 cases aged 35 and under. Am Heart J 1974; 87:689-696.
6. Hughes P, Murdock DK, Olson K, Juza R, Jenkins K, Wegner A, et al. School children have leading risk factors for cardiovascular disease and diabetes: the Wausau SCHOOL project. WMJ 2006; 105:32-39.
7. McGill HC Jr, McMahan CA, Zieske AW, Sloop GD, Walcott JV, Troxclair DA, et al. Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 2000; 20:1998-2004.
8. McGill HC Jr, Herderick EE, McMahan CA, Zieske AW, Malcolm GT, Tracy RE, et al. Atherosclerosis in youth. Minerva Pediatr 2002; 54:437-447.
9. Vorster HH, Bourne LT, Venter CS, Oosthuizen W. Contribution of nutrition to the health transition in developing countries: a framework for research and intervention. Nutr Rev 1999; 57:341-349.
10. James S, Vorster HH, Venter CS, Kruger HS, Nell TA, Veldman FJ, et al. Nutritional status influences plasma fibrinogen concentration: evidence from the THUSA survey. Thromb Res 2000; 98:383-394.
11. Barker DJP, Meade TW, Fall CHD, Lee A, Osmond C, Phipps K, et al. Relation of fetal and infant growth to plasma fibrinogen and factor VII concentrations in adult life. BMJ 1992; 304:148-152.
12. Roseboom TJ, Van Der Meulen JHP, Ravelli ACJ, Osmond C, Barker DJP, Bleker OP. Plasma fibrinogen and factor VII concentrations in adults after prenatal exposure to famine. Brit J Haematol 2000; 111:112-117.
13. Corsaut MJ, Bierma TJ, Kasa RM. Factor VIII:C relationships to selected lipids, age, and gender in healthy adults. Am J Med Sci 1990; 300:83-87.
14. Sagripanti A, Carpi A. Natural anticoagulants, aging, and thromboembolism. Exp Gerontol 1998; 33:891-896.
15. Krobot K, Hense HW, Cremer P, Eberle E, Keil U. Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Results from the second MONICA Augsburg survey 1989-1990. Arterioscler Thromb 1992; 12:780-788.
16. Mertens I, Van Gaal LF. Obesity, haemostasis and the fibrinolytic system. Obes Rev 2002; 3:85-101.
17. Barbeau P, Litaker MS, Woods KF, Lemmon CR, Humphries MC, Owens S, et al. Hemostatic and inflammatory markers in obese youths: effects of exercise and adiposity. J Pediatr 2002; 141:415-420.
18. Cook DG, Whincup PH, Miller G, Carey IM, Adshead FJ, Papacosta O, et al. Fibrinogen and factor VII levels are related to adiposity but not to fetal growth or social class in children aged 10-11 years. Am J Epidemiol 1999; 150:727-736.
19. Ferguson MA, Gutin B, Owens S, Litaker M, Tracy RP, Allison J. Fat distribution and hemostatic measures in obese children. Am J Clin Nutr 1998; 67:1136-1140.
20. Gallistl S, Sudi KM, Cvirn G, Muntean W, Borkenstein. Effects of short-term energy restriction and physical training on haemostatic risk factors for coronary heart disease in obese children and adolescents. Int J Obesity 2000; 25:529-532.
21. Elwood PC, Yarnell JWG, Pickering J, Fehily AM, O'Brien JR. Exercise, fibrinogen, and other risk factors for ischaemic heart disease. Caerphilly Prospective Heart Disease Study. Br Heart J 1993; 69:183-197.
22. Ernst E. Regular exercise reduces fibrinogen levels: a review of longitudinal studies. Br J Sports Med 1993; 27:175-176.
23. Clauss A. Physiological coagulation method for fast determination of fibrinogen. Acta Haematol (Basel) 1957; 17:237-246.
24. Katz A, Nambi SS, Mather K, Baron AD, Follman DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocr Metab 2000; 85:2402-2410.
25. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114:555-576.
26. Norton K, Olds T. Antropometrica: a textbook of body measurement for sports and health courses. Sydney: University of NSW Press; 1996.
27. ISAK. International standards for anthropometric assessment. Adelaide: National library of Australia; 2001.
28. Siri WE. Body composition from fluid spaces and density: analysis of methods. Nutrition 1993; 9:480-491.
29. Brozek J, Grande F, Anderson JT, Keys A. Densitometric analysis of body composition: revision of some quantitative assumptions. Ann N Y Acad Sci 1963; 110:113-140.
30. CDC (NCHS - United States Growth Charts). Z-score data files. http:// www.cdc.gov/nchs/about/major/nhanes/growthcharts/zscore/ zscore.htm. CDC NCHS 2000. [Accessed 10 November 2000].
31. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976; 51:170-179.
32. Trost SG, Ward DS, McGraw R, Russel RP. Validity of the previous day physical activity recall in fifth-grade children. Pediat Exerc Sci 1999; 11:341-348.
33. Ainsworth BE, Haskell WL, Leon AS, Jacobs DR, Montoye HJ, Sallis JF, et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sport Exer 1993; 25:71-80.
34. Lé ger LA, Lambert J. A maximal multistage 20-m shuttle run test to predict VO2 max. Eur J Appl Physiol Occup Physiol 1982; 49:1-12.
35. StatSoft Inc. STATISTICA (data analysis software system), version 7. StatSoft Inc 2004. www.statsoft.com.
36. Lohman TG. The use of skinfold to estimate body fatness on children and youth. J Phys Educ Recreat Dance 1987; 58:98-102.
37. Peck R, Olsen C, Devore J. Introduction to statistics and data analysis. Pacific Grove: Duxbury; 2001.
38. Ellis SM, Steyn HS. Practical significance (effect sizes) versus or in combination with statistical significance ( p-values). Manag Dyn 2003; 12:51-53.
39. Pepys MB. The acute phase response and C-reactive protein. In: Weatherall DJ, Ledingham JGG, Warrel DA, editors. Oxford textbook of medicine. New York: Oxford University Press; 1996.
40. Kruger HS, Margetts BM, Vorster HH. Evidence for relatively greater subcutaneousfatdepositioninstuntedgirlsintheNorthWestprovince, South Africa, as compared with nonstunted girls. Nutrition 2004; 20:564-569.
41. Goran MI, Gower BA, Nagy TR, Johnson RK. Developmental changes in energy expenditure and physical activity in children: evidence for a decline in physical activity in girls before puberty. Pediatrics 1998; 101:887-891.
42. Vorster HH. The emergence of cardiovascular disease during urbanisation of Africans. Public Health Nutr 2002; 5:239-243.
43. Monyeki KD, Van Lenthe FJ, Steyn NP. Obesity: does it occur in African children in a rural community in South Africa? Int J Epidemiol 1999; 28:287-292.
44. Mukuddem-Petersen J, Kruger HS. Association between stunting and overweight among 10-15-y-old children in the North West province of South Africa: the THUSA BANA Study. Int J Obesity 2004; 28:842-851.
45. Kelleher CC. Plasma fibrinogen and factor VII as risk factors for cardiovascular disease. Eur J Epidemiol 1992; 8:79-82.
46. ErnstE,SchmölzlC,Matrai A, SchrammW.Hemorheological effectsoforal contraceptives. Contraception 1989; 40:571-580.
47. Sudi KM,GallistlS,WeinhandlG,MunteanW,BorkensteinMH. Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescents. Metabolism 2000; 49:890-895.
48. Van Harmelen V, Wahrenberg H, Eriksson P, Arner P. Role of gender and genetic variance in plasminogen activator inhibitor-1 secretion from human adipose tissue. Thromb Haemost 2000; 83:304-308.
49. Stensel DJ, Lin FP, Ho TF, Aw TC. Serum lipids, serum insulin, plasma fibrinogen and aerobic capacity in obese and nonobese Singaporean boys. Int J Obesity 2001; 25:984-989.
50. Halle M, Korsten-Reck U, Wolfarth B, Berg A. Low-grade systemic inflammation in overweight children: impact of physical fitness. Exerc Immunol Rev 2004; 10:66-74.
51. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006; 17:4-12.
52. Trayhurn P, Wood IS. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 2005; 33:1078-1081.
53. Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, et al. Reduction in inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105:804-813.
54. Lowe GD, Yarnell JW, Rumley A, Bainton D, Sweetnam PM. C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis? Arterioscler Thromb Vasc Biol 2001; 21:603-610.
55. Mendall MA, Strachan DP, Butland BK, Ballam L, Morris J, Sweetnam PM, Elwood PC. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J 2000; 21:1584-1590.
56. Koenig W, Sund M, Frölich M, Fischer HG, Löwel H, Döring A, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Results from the MONICA (Monitoring Trends and Determinants inCardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99:237-242.
57. Asakawa H,TokunagaK, Kawakami F. Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy. J Diabetes Complications 2000; 14:121- 126.
58. Stegnar M, Vene N, Bozic M. Do haemostasis activation markers that predict cardiovascular disease exist? Pathophysiol Haemost Thromb 2003; 33:302-308.
59. Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Marcucci G, et al. Associations of factor VIII and von Willebrand factor with age, race, sex and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) study. Thromb Haemost 1993; 70:380-385.
60. Vaidyula VR, Rao AK, Mozzoli M, Homko C, Cheung P, Boden G. Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand. Diabetes 2006; 55:202- 208.
61. Wannamethee SG, Lowe GDO, Shaper AG, RumleyA,Lennon L,Whincup PH. The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older nondiabetic men. Atherosclerosis 2005; 181:101-108.